134642-35-6

Usage

Appearance

colorless to pale yellow liquid

Odor

pungent

Flammability

flammable
Potential harm if ingested or inhaled
Caution and proper safety protocols required when handling the chemical.

Upstream product

• 140-88-5 ethyl acrylate 
• 7042-33-3 ethyl 2-methylcinnamate 
• 100-52-7 benzaldehyde 
• 21382-82-1 (carbethoxyethylidene)triphenylphosphorane 

Downstream Products

• 1024029-92-2 4-ethoxycarbonyl-1,2-bis(iso-propoxycarbonyl)-3-phenyl-2,3-dihydro-1H-pyrazole 
• 1024029-76-2 1,2,4-tris(ethoxycarbonyl)-3-phenyl-2,3-dihydro-1H-pyrazole 
• 1204176-70-4 ethyl 2-(2-aminophenylcarbonyloxymethyl)-3-phenylprop-2-enoate 
• 1332507-19-3 C₁₆H₂₀O₃ 
• 1400800-38-5 C₂₁H₂₀O₃ 
• 1400800-51-2 C₂₁H₂₀O₂ 
• 1400800-52-3 C₂₀H₁₇FO₂ 
• 96851-41-1 C₂₀H₁₈O₂ 
• 1400800-35-2 C₂₀H₁₈O₂ 
• 1400800-59-0 C₁₇H₁₈O₄ 
• 1400800-60-3 C₂₂H₃₀O₂ 

Relevant academic research and scientific papers

An efficient synthesis of dihydrobenzo[c]azepines from Morita-Baylis-Hillman adducts via Pictet-Spengler reaction

Various dihydrobenzo[c]azepines were synthesized in good yields via Pictet-Spengler cyclization protocol from tosylamide derivatives of Morita-Baylis-Hillman adducts and 1,3,5-trioxane. The synthesis was carried out in the presence of easily removable mon

α-Methylene-γ-butyrolactones attenuate Staphylococcus aureus virulence by inhibition of transcriptional regulation

Bacterial pathogenesis is triggered by complex molecular mechanisms that sense bacterial density within an infected host and induce the expression of toxins for overriding the immune response. Virulence is controlled by a set of transcriptional regulators

VITAMIN D3 LACTONE DERIVATIVE

A compound represented by the following Formula (1) that is effective for the treatment of Paget's disease of bone or hypercalcemia or a medically acceptable solvate thereof; [wherein R1 refers to hydrogen atom, C1-C6 alky